GlassScriptPhysician profile
Susan M Carney
NPI 1861595464
$1,977.20
in general payments reported to CMS, 2019-2025
23 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $522 · 2020: $238 · 2021: $272 · 2022: $322 · 2023: $335 · 2024: $147 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $442.79 | 2019-2025 | Clareon, Argos |
| Sun Pharmaceutical Industries INC. | $306.58 | 2019-2025 | Cequa |
| Novartis Pharmaceuticals Corporation | $212.10 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $173.41 | 2019-2021 | |
| Oyster Point Pharma, INC. | $127.14 | 2022-2024 | Tyrvaya, Ryzumvi |
| Kala Pharmaceuticals, INC. | $119.00 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $87.73 | 2023-2025 | Acthar |
| Bausch & Lomb Americas INC. | $86.83 | 2022-2025 | Ic-8 Apthera Iol, Xiidra, Vyzulta |
| Allergan, INC. | $74.63 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $65.28 | 2024-2025 | Xdemvy |
| Alcon Research LLC | $35.28 | 2019 | |
| Glaukos Corporation | $33.51 | 2019-2021 | |
| Thea Pharma INC. | $24.42 | 2022 | |
| Aerie Pharmaceuticals, INC. | $23.48 | 2020 | |
| Harrow Eye, LLC | $22.86 | 2023 | Iheezo |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| The Cameron-Ehlen Group, INC. | $21.97 | 2021 | |
| Omeros Corporation | $19.40 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Dompe US, INC. | $17.85 | 2025 | Oxervate |
| Abbvie INC. | $17.78 | 2023 | Durysta |
| Eyepoint US, INC. | $16.58 | 2019 | |
| Rxsight INC | $14.70 | 2022 | |
| Carl Zeiss Meditec, INC. | $14.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Carney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.